Purpose | Patients | Evaluations | Perceived Effectiveness |
---|---|---|---|
Idiopathic pulmonary fibrosis | 2,872 | 353 | |
Chronic obstructive pulmonary disease | 2,430 | 103 | |
Pulmonary hypertension | 217 | 53 | |
Interstitial lung disease | 178 | 40 | |
Sleep apnea disorder | 119 | 22 |
Common side effects
Side effect | Patients | Percentage |
---|---|---|
Dry mouth | 11 | |
Nosebleeds (epistaxis) | 10 | |
Runny nose (rhinorrhea) | 7 | |
Dry nasal passages | 5 | |
Sore nose | 5 | |
Dry mouth at night | 3 |
Side effect severity
Severity | Evaluations | Percentage |
---|---|---|
Severe | 2 | |
Moderate | 36 | |
Mild | 83 | |
None | 446 |
Member evaluations
gagafor2
evaluated on Sep 27, 2018
- Perceived effectiveness for idiopathic pulmonary fibrosis: Major
- Side effects: None
KipWong
evaluated on Feb 28, 2017
- Perceived effectiveness for decreased diaphragm strength: Moderate
- Side effects: None
thjuland
evaluated on Sep 30, 2016
- Perceived effectiveness for chronic obstructive pulmonary disease: Major
- Side effects: None